Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAOA | P21397 | 1/20 | 0.41 |
| ▸ | MAOB | P27338 | 1/20 | 0.41 |
| ▸ | PTPN1 | P18031 | 1/20 | 0.39 |
| ▸ | TEK | Q02763 | 1/20 | 0.39 |
| ▸ | MEN1 | O00255 | 1/20 | 0.38 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.38 |
| ▸ | IDH1 | O75874 | 3/20 | 0.36 |
| ▸ | LMNA | P02545 | 1/20 | 0.35 |
| ▸ | CALM1 | P0DP23 | 1/20 | 0.34 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.33 |
| ▸ | GLA | P06280 | 1/20 | 0.33 |
| ▸ | HPGD | P15428 | 1/20 | 0.33 |
| ▸ | DAO | P14920 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL25834692 | 0.85 | MAOA (0.44) | MAOAMAOBPTPN1TEKMEN1 | |
| SCHEMBL25834365 | 0.71 | BACE1 (0.38) | MAOAMAOBPTPN1MEN1KMT2A | |
| SCHEMBL25835348 | 0.69 | MAOA (0.42) | MAOAMAOBPTPN1TEKMEN1 | |
| SCHEMBL2515239 | 0.64 | MAOA (0.69) | MAOAMAOBPTPN1TEKMEN1 | |
| SCHEMBL9621772 | 0.61 | MAOA (0.41) | MAOAMAOBPTPN1TEKMEN1 | |
| SCHEMBL17480820 | 0.60 | CYP1A2 (0.44) | MAOAMAOBIDH1LMNACALM1 | |
| Diphenylmethane SCHEMBL10394702 | 0.60 | CALM1 (0.92) | IDH1LMNACALM1ALDH1A1 | |
| Diphenylmethane SCHEMBL11601786 | 0.59 | CALM1 (0.67) | PTPN1MEN1KMT2AIDH1LMNA | |
| SCHEMBL720415 | 0.59 | MAOA (0.46) | MAOAMAOBPTPN1TEKLMNA | |
| SCHEMBL6866056 | 0.59 | MAOA (0.42) | MAOAMAOBPTPN1TEKIDH1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230227393-A1 | IRON CATALYZED HIGHLY ENANTIOSELECTIVE CIS-DIHYDROXYLATION OF QUINONES | THE UNIVERSITY OF HONG KONG (CN) | 2023-07-20 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230227393-A1 | IRON CATALYZED HIGHLY ENANTIOSELECTIVE CIS-DIHYDROXYLATION OF QUINONES | NFE2L2, DUOX1, DUOX2 | MAOA 44/4885MAOB 90/4885PTPN1 4633/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.